2025 Clover Health Medicare Advantage Benefits Demonstrate Commitment to New Jersey Seniors
Clover Health (Nasdaq: CLOV) has unveiled its 2025 Medicare Advantage (MA) plan offerings in New Jersey, focusing on affordable and flexible healthcare options for seniors. The company's flagship PPO plans, which serve over 95% of its MA membership, have received a 4 Star rating from CMS. Clover's 2025 plans include:
- Low specialist and prescription drug copays
- Enhanced OTC and dental allowances
- A rewards program offering up to $400 annually for healthy activities
- Competitive in-network and out-of-network costs for PPO plans
CEO Jamie Reynoso emphasized Clover's commitment to providing stability and increased value for members, especially during a time when many plans are scaling back benefits. The company aims to help New Jersey seniors manage their healthcare costs while maintaining quality and affordability.
Clover Health (Nasdaq: CLOV) ha presentato le sue offerte di piano Medicare Advantage (MA) per il 2025 nel New Jersey, concentrandosi su opzioni sanitarie accessibili e flessibili per gli anziani. I piani PPO di punta dell'azienda, che servono oltre il 95% dei suoi membri MA, hanno ricevuto una valutazione di 4 Stelle dalla CMS. I piani del 2025 di Clover includono:
- Basse franchigie per specialisti e farmaci
- Aumenti delle indennità per prodotti OTC e odontoiatrici
- Un programma di premi che offre fino a 400 dollari all'anno per attività salutari
- Costi competitivi per piani PPO sia in rete che fuori rete
Il CEO Jamie Reynoso ha sottolineato l'impegno di Clover a fornire stabilità e un valore aumentato per i membri, specialmente in un periodo in cui molti piani stanno riducendo i benefici. L'azienda mira ad aiutare gli anziani del New Jersey a gestire i costi sanitaria mantenendo qualità e accessibilità.
Clover Health (Nasdaq: CLOV) ha presentado sus ofertas de planes Medicare Advantage (MA) para 2025 en Nueva Jersey, enfocándose en opciones de atención médica asequibles y flexibles para los ancianos. Los planes PPO insignia de la empresa, que sirven a más del 95% de sus miembros MA, han recibido una calificación de 4 estrellas de la CMS. Los planes de Clover para 2025 incluyen:
- Bajos copagos para especialistas y medicamentos recetados
- Aumentos en las asignaciones de productos OTC y odontológicos
- Un programa de recompensas que ofrece hasta $400 anuales por actividades saludables
- Costos competitivos para planes PPO tanto en red como fuera de red
El CEO Jamie Reynoso enfatizó el compromiso de Clover de proporcionar estabilidad y un valor aumentado para los miembros, especialmente en un momento en que muchos planes están reduciendo beneficios. La empresa tiene como objetivo ayudar a los ancianos de Nueva Jersey a gestionar sus costos de atención médica mientras mantiene calidad y asequibilidad.
Clover Health (Nasdaq: CLOV)가 2025년 뉴저지주 메디케어 어드밴티지(MA) 플랜을 공개했습니다. 이는 노인을 위한 저렴하고 유연한 의료 옵션에 초점을 맞추고 있습니다. 이 회사의 대표적인 PPO 플랜은 MA 회원의 95% 이상을 지원하며, CMS로부터 4성급 평점을 받았습니다. Clover의 2025년 플랜은 다음과 같습니다:
- 저렴한 전문의 및 처방약 코페이
- 향상된 OTC 및 치과 수당
- 건강한 활동에 대해 연간 최대 400달러를 제공하는 보상 프로그램
- PPO 플랜의 네트워크 내 및 외의 경쟁력 있는 비용
CEO Jamie Reynoso는 많은 플랜들이 혜택을 축소하는 시기에 Clover가 회원들에게 안정성과 향상된 가치를 제공하겠다는 의지를 강조했습니다. 이 회사는 뉴저지 노인들이 의료 비용을 관리하면서 품질과 저렴함을 유지할 수 있도록 지원하는 것을 목표로 하고 있습니다.
Clover Health (Nasdaq: CLOV) a dévoilé ses offres de plans Medicare Advantage (MA) pour 2025 dans le New Jersey, en se concentrant sur des options de soins de santé abordables et flexibles pour les seniors. Les principaux plans PPO de l'entreprise, qui servent plus de 95 % de ses membres MA, ont reçu une note de 4 étoiles de la CMS. Les plans 2025 de Clover comprennent :
- Faibles quotes-parts pour spécialistes et médicaments sur ordonnance
- Augmentations des allocations OTC et dentaires
- Un programme de récompenses offrant jusqu'à 400 $ par an pour des activités saines
- Coûts compétitifs pour les plans PPO, en réseau et hors réseau
Le PDG Jamie Reynoso a souligné l'engagement de Clover à fournir stabilité et valeur accrue aux membres, en particulier à un moment où de nombreux plans réduisent les prestations. L'entreprise vise à aider les seniors du New Jersey à gérer leurs coûts de santé tout en maintenant qualité et accessibilité.
Clover Health (Nasdaq: CLOV) hat seine Medicare Advantage (MA) Planangebote für 2025 in New Jersey vorgestellt, mit einem Fokus auf erschwingliche und flexible Gesundheitsoptionen für Senioren. Die Flaggschiff-PPO-Pläne des Unternehmens, die über 95% seiner MA-Mitglieder bedienen, haben von der CMS eine 4-Sterne-Bewertung erhalten. Die Pläne von Clover für 2025 beinhalten:
- Niedrige Zuzahlungen für Fachärzte und verschreibungspflichtige Medikamente
- Erhöhte OTC- und Zahnzusatzleistungen
- Ein Belohnungsprogramm, das bis zu 400 Dollar jährlich für gesunde Aktivitäten anbietet
- Wettbewerbsfähige Kosten für PPO-Pläne sowohl im Netzwerk als auch außerhalb des Netzwerks
CEO Jamie Reynoso betonte das Engagement von Clover, Stabilität und einen erhöhten Wert für die Mitglieder bereitzustellen, insbesondere in einer Zeit, in der viele Pläne die Leistungen reduzieren. Das Unternehmen zielt darauf ab, Senioren in New Jersey zu helfen, ihre Gesundheitskosten zu managen und gleichzeitig Qualität und Erschwinglichkeit aufrechtzuerhalten.
- Clover Health's flagship PPO plans received a 4 Star rating from CMS
- Over 95% of Clover's Medicare Advantage membership is served through PPO plans
- Introduction of a rewards program offering up to $400 annually for completing healthy activities
- Enhanced OTC and dental allowances for 2025 plans
- Low specialist and prescription drug copays maintained for 2025
- None.
Company’s affordable, benefit-rich flagship PPO plans now have 4 Star rating
FRANKLIN, Tenn., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV) (“Clover” or “the Company”) has announced the debut of its 2025 Medicare Advantage (MA) plan offerings in New Jersey. Clover offers a range of affordable and flexible healthcare options for Medicare beneficiaries, which are designed to meet the unique needs of New Jersey seniors, especially those on fixed incomes facing rising costs of living.
For full plan details, availability, and eligibility visit https://www.cloverhealth.com/plans.
“We are proud to reaffirm our commitment to New Jersey by maintaining our affordable benefit-rich PPO plans for 2025,” said Jamie Reynoso, Clover’s CEO of Medicare Advantage. “At a time when many plans are scaling back, Clover is the calm in the eye of the storm, delivering stability and increased value for our members.”
Clover’s 2025 plans in New Jersey focus on PPOs, but also include HMO offerings to cater to a wide range of healthcare needs. PPO plans offer highly competitive in-network and out-of-network costs, empowering members to access the care they need without the burden of high out-of-pocket expenses. For 2025, Clover has strengthened its product positioning to minimize disruption while delivering added value to members including low specialist and prescription drug copays, enhanced OTC and dental allowances, and a rewards program with the potential to earn up to
“After a decade of serving New Jersey’s Medicare beneficiaries, we understand the unique struggles they face, and we are committed to providing plans that deliver premium value as well as help them manage their day-to-day healthcare costs,” added Reynoso. “From offering the
Clover’s 2025 PPO plans received a 4 Star rating from the Centers for Medicare and Medicaid Services (“CMS”). Currently, over
For information on Clover Health’s Medicare Advantage plans, visit www.cloverhealth.com.
Federal Contracting Disclaimer: Clover Health is a Preferred Provider Organization (PPO) and a Health Maintenance Organization (HMO) with a Medicare contract. Enrollment in Clover Health depends on contract renewal.
The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the accuracy and completeness of the information contained in this document.
Material ID: Y0129_24EX069_M
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Press Contact:
Andrew Still-Baxter
press@cloverhealth.com
Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com
FAQ
What are the key features of Clover Health's 2025 Medicare Advantage plans in New Jersey?
What Star rating did Clover Health's PPO plans receive for 2025?
How much can Clover Health members earn through the rewards program in 2025?
What percentage of Clover Health's Medicare Advantage membership is served through PPO plans?
